Monash Proteomics and Metabolomics Platform (MPMP) - Drug Target Identification Node

Overview

MPMP perform targeted and untargeted proteomics, lipidomics and metabolomics studies for a wide range of biomedical and pharmaceutical applications.

Capabilities

Equipment

Metabolomics Equipment

LC-MS: Exploris 120 with Vanquish, and Q-Exactive Orbitrap with Dionex U3000. Established informatics workflows (IDEOM) and extensive metabolite library.

Proteomics Equipment

LC-MS: Orbitrap Astral, Orbitrap Exploris 480 with nano-LC. Established informatics workflows (Maxquant, Spectronaut, LFQAnalyst)

Lipidomics Equipment

LC-MS: Exploris 120 with Vanquish, and Q-Exactive Orbitrap with Dionex U3000. Established informatics workflows (IDEOM and DIPL).

Access Information

Projects can be conducted on a fee-for-service, collaborative (cost-recovery) or self-user basis. For further details please visit: www.monash.edu/researchinfrastructure/mpmp

Contacts

Professor Darren Creek
MPMP - Drug Target Identification Node Director - 03 9903 9249
darren.creek@monash.edu

Team Members

Dr Dovile Anderson
Metabolomics and Lipidomics
dovile.anderson@monash.edu

Dr Ghizal Siddiqui
Proteomics
ghizal.siddiqui@monash.edu

Images